Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2020 May 5;10:701. doi: 10.3389/fonc.2020.00701

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

Mubalake Abudoureyimu 1, Yongting Lai 2, Chuan Tian 1, Ting Wang 3, Rui Wang 1,*, Xiaoyuan Chu 1
PMCID: PMC7215169  PMID: 32432043

In the original article, we neglected to include the funder the Excellent Youth Foundation of Jiangsu Province, China, BK20140032 to Rui Wang.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES